secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dermata Therapeutics, Inc. (DRMA)
CIK:        0001853816
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001654954-24-000520
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Dermata shareholders approve warrant issuance and auditor ratification at special meeting
--------------------------------------------------------------------------------

- Issuance Proposal: 789,001 for, 5,008 against, 231 abstain, 485,871 broker non-votes — approved.
- Ratification of Moss Adams LLP as independent auditor for FY 2023: 1,269,895 for, 9,551 against, 665 abstain — approved.
- Adjournment Proposal: 788,925 for, 4,893 against, 422 abstain, 485,871 broker non-votes — approved.
- Special meeting held January 12, 2024; record date November 17, 2023 with 3,189,034 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424000520/0001654954-24-000520-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1853816/000165495424000520/drma_8k.htm
  HTML page:      https://secwatch.observer/filing/0001654954-24-000520

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer